In 1978, the birth of the first child conceived through IVF changed how medicine understood its own limits. Since then, assisted reproductive technologies have evolved dramatically: from manual embryo evaluation under a microscope to artificial intelligence systems capable of predicting blastocyst viability based on thousands of time-lapse images. Today, surrogacy https://www.mother-surrogate.com/ is not only a legal agreement and a medical protocol, but also a complex technological system in which key decisions are supported by data.
Artificial Intelligence in the Laboratory
One of the most significant shifts in recent years has occurred in embryology. A study published in npj Digital Medicine (Nature, 2024) describes how AI systems analyze data from thousands of IVF cycles to help personalize treatment: selecting initial gonadotropin doses, tracking follicle development in real time, and predicting the outcome of embryo transfer with a level of accuracy difficult for a single specialist to achieve.
One of the most illustrative technologies is EmbryoScope, an incubator equipped with a built-in time-lapse camera. It records embryo development every few minutes without removing the embryo from its optimal environment and transmits the images to an AI algorithm that evaluates morphokinetics—the dynamics of cell division. This system allows embryologists to select the most promising embryos for transfer based on objective, reproducible criteria rather than solely on subjective visual assessment.
Genetic Screening: From Diagnosis to Prevention
Preimplantation genetic testing (PGT) has become a standard component of high-quality surrogacy programs. Its three main types address different clinical tasks:
- PGT-A — screening for aneuploidy (abnormal chromosome number), the leading cause of implantation failure and early miscarriage;
- PGT-M — testing for specific monogenic diseases when parents have a known hereditary risk;
- PGT-SR — analysis of structural chromosomal rearrangements.
Particular attention is now given to non-invasive PGT (niPGT). This technology analyzes cell-free embryonic DNA found in the culture medium, allowing genetic assessment without direct contact with the embryo.
Telemedicine and Digital Coordination
For international couples, technology has also changed how they participate in surrogacy programs. Many consultations that previously required travel are now conducted remotely: initial meetings with reproductive specialists, discussions of treatment protocols, psychological sessions, and legal consultations. During the pregnancy, intended parents can receive the results of routine examinations in real time through secure medical platforms.
At the same time, digital monitoring tools for surrogate mothers are becoming more common. Wearable devices and specialized applications allow health indicators to be tracked without unnecessary clinic visits, which is particularly valuable in regions where medical infrastructure is less dense.
What This Means for Intended Parents
Technology does not eliminate the emotional complexity of surrogacy, but it makes the process more predictable. Quantitative data, standardized protocols, and documented medical information reduce uncertainty at every stage. Couples entering a program today have access to tools that did not exist even a decade ago.
Ukraine is one of the clearest examples of countries where advanced reproductive technology is combined with a well-defined legal framework. Ukrainian fertility centers operate according to ESHRE standards, use time-lapse incubation systems, PGT, and biomaterial verification technologies, while remaining significantly more affordable than clinics in the United States or Western Europe. For international couples, this means access to technologically advanced programs without having to choose between quality and cost.